Keynumbers for: IDL Biotech

 6/30/201012/31/20106/30/201112/31/20116/30/201212/31/20126/30/201312/31/2013
Number of months that the report spans612612612612
Total revenue (MSEK)8.0716.497.8515.339.1817.4510.8922.40
Earnings before interest and taxes (EBIT) (MSEK)-0.95-2.24-0.60-3.39-2.14-5.48-1.47-1.87
Pre tax profit (PTP) (MSEK)-0.992.24-1.03-3.52-2.23-5.58-1.56-2.10
Net Revenue (MSEK)-0.99-2.34-1.13-3.52-2.23-5.58-1.56-2.10
Earnings per share (SEK)-0.05-0.12-0.06-0.18-0.12-0.24-0.06-0.08
Dividend per share (SEK)--------
Owner's equity (MSEK)6.184.828.706.3010.567.215.655.11
Fixed assets (MSEK)4.845.355.315.295.385.415.426.17
Intangible assets (MSEK)---4.684.885.025.144.75
Liquid assets (MSEK)8.077.038.358.1110.068.059.2811.34
Total shareholder equity and liabilities (MSEK)--13.6613.3915.4413.4614.7017.51
Long time debts including distributions (MSEK)-0.290.220.150.08--0.75
Short term debt (MSEK)-6.737.274.756.954.806.259.0511.64
The share's par value (SEK)0.800.800.400.400.40.40.400.40
Cash flow for the period (MSEK)--0.100.46-47.35-0.15-0.170.65
Number of shares (in millions)--19 057 04319 057 04319 057 04327 338 18927 338 18927 338 189
Average number of employees1111111211131211

  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se